Introduction
The cancer stem cell (CSC) theory states that only a small population of cells within a tumor is tumorigenic and has the ability for self-renewal (1) . CSCs are thought to be related to tumor recurrence and treatment resistance; even though we treat non-CSCs by surgery or chemotherapy, relapse or metastasis may result if CSCs should resist (2) . This theory was first suggested in leukemia, and many studies investigating CSCs are now performed in various types of solid tumors such as glioblastoma, colon cancer, breast cancer and prostate cancer (3) (4) (5) (6) (7) . Undifferentiated-cell (normal stem cell) markers such as Nanog, OCT3/4 and SOX2 are known to be expressed in a small population of cancer cells (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Increasing evidence suggests that tumor tissues are not homogeneous but heterogeneous supporting the CSC hypothesis.
Gremlin 1 is one of the bone morphogenetic protein (BMP) antagonists and especially antagonizes with BMP2, BMP4 and BMP7 (18, 19) . BMPs are members of the transforming growth factor (TGF)-β superfamily and play an essential role during development and differentiation while Gremlin 1 is also related to differentiation in combination with BMPs and its dysregulation results in developmental diseases (20) (21) (22) (23) . Gremlin 1 is overexpressed in various types of human cancers (24) (25) (26) . Recently several studies have demonstrated that CSCs prevent the BMP differentiating effect by secreting Gremlin 1 in glioblastoma, suggesting that Gremlin 1 plays a role in maintenance of CSC properties (27, 28) . In gynecological malignancies such as ovarian, endometrial and cervical cancers, various techniques to isolate cells with CSC-like properties have been reported. For instance, CD44-or CD133-positive cells are known to be more tumorigenic than negative ones in ovarian cancer (29, 30) . Similar findings have been suggested for side population (SP) cells in endometrial cancer and ALDH1-positive cells in cervical cancer (31) (32) (33) (34) (35) (36) . Gremlin 1 is also reported to be expressed in cervical cancer compared to normal tissues of the cervix (37) . A few studies have investigated the significance of BMPs in cervical cancer (38) (39) (40) , however, there are no studies on the clinicopathological significance of Gremlin 1 in cervical cancer nor on the function of Gremlin 1 in CSC-like cells of cervical cancer.
Viewing the importance of Gremlin 1 in CSC maintenance and expression of Gremlin 1 in cervical cancer tissue, we hypothesized that Gremlin 1 may be correlated with the prognosis of cervical cancer through maintaining CSC properties. In the present study, we first demonstrated the clinicopathological significance of Gremlin 1 in stage I-II cervical cancer patients and the in vitro promoting effects of Gremlin 1 on CSC properties in cervical cancer cells.
Materials and methods
Patients. The present study was approved by the Institutional Ethics Committee, and written informed consent was obtained from each patient. Patients with a diagnosis of cervical cancer (stage Ⅰ-Ⅱ) who underwent primary surgery at the University of Tokyo Hospital from 2005 to 2014 were enrolled. A total of 104 samples were obtained.
RNA extraction and RT-quantitative PCR (RT-qPCR).
Cervical cancer tissues (100-200 mg) were collected and snap frozen with liquid nitrogen and preserved at -80˚C. Tissues were homogenized using MagNA Lyser Instrument (Roche Diagnostics, Mannheim, Germany) and total RNA was extracted with a Tissue Total RNA kit (Favorgen Biotech Corp., Ping-Tung, Taiwan) according to the manufacturer's protocols. First-strand cDNA was synthesized (reverse transcription reactions) from 1 µg of total RNA using ReverTra Ace (Toyobo, Osaka, japan). RT-qPCR was performed with SYBR-Green PCR Master Mix (Roche Diagnostics) according to the manufacturer's instructions. β-actin was used as a housekeeping gene, and the results are represented as foldchange relative to β-actin expression (2 -ΔΔCt ). The sequences of the primer pairs used were as follows: Gremlin 1, forward, 5'-TCATCAACCGCTTCTGTTACGGC-3' and reverse, 5'-CAGAAGGAGCAGGACTGAAAGG-3'; Nanog, forward 5'-GCTGAGATGCCTCACACGGAG-3' and reverse 5'-TCTGTTTCTTGACCGGGACCTTGTC-3'; OCT3/4, forward 5'-TGGAGAAGGAGAAGCTGGAGCAAAA-3' and reverse 5'-GGCAGATGGTCGTTTGGCTGAATA-3'; SOX2, forward 5'-GGAAATGGGAGGGGTGCAAAAGAGG-3' and reverse 5'-TTGCGTGAGTGTGGATGGGATTGGTG-3'; β-actin, forward 5'-CTGGAACGGTGAAGGTGACA-3' and reverse 5'-A AG G GAC T TCC TGTA ACA ACG CA-3'. Denaturation was performed at 95˚C for 2 min, followed by 35 cycles at 98˚C for 10 sec, at 65˚C for 10 sec and at 68˚C for 8 sec. Each experiment was performed in triplicate and repeated three times.
Cell culture. The human squamous cell carcinoma cell line CaSki (derived from a metastatic site; small intestine) was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in adherent conditions in Dulbecco's modified Eagle's medium (DMEM; wako Pure Chemical Industries Ltd., Osaka, japan) supplemented with 10% fetal bovine serum (FBS; Invitrogen Life Technologies, Carlsbad, CA, USA) and sub-cultured by 0.25% trypsin/EDTA (wako Pure Chemical Industries Ltd.) detachment. For the sphere-forming assays, DMEM/F12 (Invitrogen Life Technologies) supplemented with 20 ng/ml human recombinant epidermal growth factor (EGF; wako Pure Chemical Industries Ltd.), 10 ng/ml basic fibroblastic growth factor (bFGF; ReproCELL, Inc., kanagawa, japan) and 0.3% bovine serum albumin (BSA; Sigma-Aldrich Co., St. Louis, MO, USA) (sphere medium) was used. Each medium contained no antibiotics. All cells were grown and treated in a humidified atmosphere at 37˚C and 5% CO 2 . when 60-70% confluence was reached, the medium was replaced with DMEM containing 0.5% FBS and 1,000 ng/ml human recombinant Gremlin 1 (R&D Systems Inc., Minneapolis, MN, USA) or vehicle for another 24 h and total RNA was extracted.
Flow cytometry. The ALDH enzymatic activity of the cells was measured using the ALDEFLUOR kit (StemCell Technologies, Vancouver, BC, Canada) according to the manufacturer's protocol. CaSki cells (1x10 6 cells) were suspended in ALDEFLUOR assay buffer containing ALDH substrate. The brightly fluorescent ALDH-positive cells were detected using FACSCalibur flow cytometer (BD Biosciences, San jose, CA, USA). As a negative control, cells were stained under identical conditions after treatment with the specific ALDH inhibitor N,N-diethylaminobenzaldehyde (DEAB). For obtaining consistent results, the following conditions were applied; 2x10 5 cells were seeded onto a 6-well multiplate dish in triplicate for 48 h and medium was switched to DMEM containing 3% FBS and Gremlin 1 (1,000 ng/ml) or vehicle for another 24 h and flow cytometry was performed as described above. Each experiment was repeated three times.
Sphere-forming assay. CaSki cells were cultured under the conditions described for flow cytometry, and then the sphere-forming assay was performed. Dissociated single cells (1,000 cells) were seeded onto ultra-low attachment multi-plate (24-well) dish (Corning Inc., Corning, NY, USA) in quadruplicate and cultured in sphere medium for another 7 days. After that, spheroids larger than 100 µm in diameter were counted, and the number of spheroids was compared between the Gremlin 1-exposed cells and the control (vehicle). Each experiment was repeated three times.
Statistical analysis. known clinicopathological prognostic factors and expression of Gremlin 1 mRNA were analyzed by univariate Cox proportional hazards regression models, and the relative risk (RR) with 95% confidence intervals (CIs) was evaluated. Logistic regression analysis was performed to investigate the relationship between Gremlin 1 mRNA expression level and recurrence. Using this result, receiver operating characteristic (ROC) curves were used to assess the criterion value. kaplan-Meier curves were used to estimate the probability of OS and PFS, and the log-rank test was used to compare survival between the two groups (high Gremlin 1 mRNA or low Gremlin 1 mRNA levels). A χ 2 test was used to evaluate the relationship between expression of Gremlin 1 and each clinicopathological factor. For the in vitro study, the Student's t-test was used to compare the data obtained for the controls. P<0.05 was considered to indicate a statistically significant difference. jMP ® (SAS Institute) was used for statistical analysis.
Results

Expression of Gremlin 1 in cervical cancer tissues is significantly correlated with progression-free survival (PFS) and recurrence.
Characteristics of the 104 patients whose cancer tissues were collected are shown in Table Ⅰ . Expression of Gremlin 1 mRNA was not a significant prognostic factor for overall survival (OS) in the univariate analysis (Table Ⅱ) but was a prognostic factor for PFS in both univariate and multivariate analyses as well as histology (non-squamous carcinoma) ( Table Ⅲ) . Expression of Gremlin 1 mRNA was also significantly correlated with recurrence in the logistic regression analysis. Cut-off value for high and low expression was set using ROC curves; high expression of Gremlin 1 mRNA, >0.20; low expression, <0.20 ( Fig. 1) . kaplan-Meier curves for OS and PFS in patients with high and low Gremlin 1 mRNA expression are shown in Fig. 2 . High expression of Gremlin 1 mRNA was a significant prognostic factor for PFS (log-rank test, P=0.0004). increased the expression of Nanog mRNA but not Oct3/4 and Sox2 mRNA (Fig. 3A) . Likewise, exposing CaSki cells to Gremlin 1 significantly (~1.41-fold) increased the population of ALDH1-positive cells compared to the control (Fig. 3B) . These results were not obtained when the concentration of Gremlin 1 was reduced to 500 ng/ml (data not shown).
Univariate Multivariate -----------------------------------------------------------------------------------------------------------------------------------------------
Exposing CaSki cells to Gremlin 1 increases sphere-forming ability.
we then investigated the sphere-forming ability of Gremlin 1-exposed cells. Significantly more spheroids were formed when 1,000 cells of Gremlin 1-exposed cells were seeded compared to the control (Fig. 4A) . A representative counted spheroid (>100 µm in diameter) is shown in Fig. 4B .
Discussion
Here, we investigated the clinical significance of Gremlin 1 in cervical cancer and then investigated its effects on cancer cells in vitro.
The CSC theory states that only a small population of cells within a tumor is tumorigenic and has the ability for self-renewal. Increasing evidence suggests that tumor tissues are not homogeneous but heterogeneous and supports the CSC hypothesis in cervical cancer as well. Recently, Gremlin 1 has been suggested to be secreted by CSCs in glioblastoma and prevents CSCs from differentiating by its antagonistic effect on BMPs.
First, we showed that high expression of Gremlin 1 mRNA in cervical cancer tissues is a significant prognostic factor for PFS and clinical recurrence. High expression of Gremlin 1 mRNA was significantly correlated with a bulky (>4 cm) tumor, which is one of the most malignant features of cervical cancer. However, these findings should not be interpreted to conclude that cases of poor prognosis have a larger population of CSCs. Gremlin 1 was found to be secreted from stromal cancer-associated fibroblast (CAFs) in colon cancer and its expression was localized to invasion fronts (24) (25) (26) . On the other hand, Gremlin 1 was found to be secreted by CSCs in glioblastoma and was thought to prevent CSCs from differentiating by antagonizing the effects ofBMPs (27, 28) . Although there are no common views about the distribution pattern of Gremlin 1 expression in cervical cancer (37), we may safely say that a microenvironment of high expression of Gremlin 1 is favorable for CSC maintenance or invasion. In an in vitro study, we revealed the effects of Gremlin 1 on CSC-like properties. The exposure of CaSki cells to Gremlin 1 (1,000 ng/ml) increased: i) Nanog mRNA expression levels (but not Oct3/4 and Sox2 mRNA expression levels), ii) the population of ALDH-positive cells (1.41-fold higher compared with the control) and iii) sphere-forming ability when 1,000 Gremlin 1-exposed cells were seeded.
The effects of Gremlin 1 may have been obtained by preventing CSCs from differentiating or promoting non-CSCs to de-differentiate. we investigated changes in the population of ALDH1-positive CaSki cells in normal culture medium at each day after 48 h of seeding (Fig. 5) . After 48 h of seeding, >60% of adherent cells were ALDH1-positive and those percentages were reduced to ~30% upon reaching confluency, which are compatible with previous reports that the ALDH1-positive population in CaSki cells are 20-30% (32) . In our experiments of Gremlin 1-exposure, the cells were ~60-70% confluent after 48 h of seeding (when we exposed cells to Gremlin 1) and became 90-100% confluent when assessed after 72 h of seeding. Considering this fact and a previous report that ALDH1-negative cells do not become ALDH-positive (32), the effects of Gremlin 1 that we observed were achieved by preventing CSCs from differentiating to some extent resulting in increased sphere-forming ability.
Gremlin 1 specifically antagonizes BMP2, BMP4 and BMP7 function among the various members of BMPs (19) . we performed the same experiments using BMP2, BMP4 and BMP7 (500 ng/ml). Only exposure of CaSki cells to BMP7 significantly reduced the expression of Nanog mRNA expression. However, the population of ALDH1-positive cells was not significantly different even between BMP7-exposed cells and the vehicle control (data not shown). This fact suggests that the BMP/Gremlin 1 axis is complex and we should not only consider high and low expression of BMPs or Gremlin 1 but the combination is important. Gremlin 1 is thought to have various effects on non-BMP signaling (41) . we performed the same experiments using LDN-193189 [a small molecule inhibitor of BMP type I receptors ALk2 and ALk3 (42) (43) (44) ] to confirm that our obtained results of Gremlin 1 were via BMP signaling. Exposure of CaSki cells to LDN-193189 increased the expression of Nanog mRNA in a dose-dependent manner and significantly high expression of Nanog mRNA was observed compared to the vehicle control when the concentration of LDN-193189 was 100 nM (data not shown).
In conclusion, we demonstrated the clinical significance of Gremlin 1 in cervical cancer and insights into its effects on CSC-like properties in vitro were shown. In cervical cancer, it is suggested that Gremlin 1 may play a role in clinical recurrence and maintaining CSC-like properties. (A) After exposure to Gremlin 1 (1,000 ng/ml) for 24 h, dissociated single cells (1,000 cells) were seeded onto an ultra-low attachment dish cultured in sphere medium for another 7 days. Significantly more spheroids were formed (t-test, P=0.0379). Experiments were performed in quadruplicate and repeated three times. The values shown represent the mean ± SD. x-axis, control or Gremlin 1 group; y-axis, number of spheroids. (B) A representative spheroid (>100 µm in diameter) is shown. Bar, 100 µm.
